Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jacquelyn Bainbridge to Humans

This is a "connection" page, showing publications Jacquelyn Bainbridge has written about Humans.

 
Connection Strength
  
 
 
0.169
  
  1. Janson MT, Bainbridge JL. Continuing Burden of Refractory Epilepsy. Ann Pharmacother. 2021 03; 55(3):406-408.
    View in: PubMed
    Score: 0.020
  2. Dopheide JA, Bostwick JR, Goldstone LW, Thomas K, Nemire R, Gable KN, Cates M, Caballero J, Smith T, Bainbridge J. Curriculum in Psychiatry and Neurology for Pharmacy Programs. Am J Pharm Educ. 2017 Sep; 81(7):5925.
    View in: PubMed
    Score: 0.016
  3. Habibi M, Hart F, Bainbridge J. The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs. Curr Neurol Neurosci Rep. 2016 08; 16(8):71.
    View in: PubMed
    Score: 0.015
  4. Hart FM, Bainbridge J. Current and emerging treatment of multiple sclerosis. Am J Manag Care. 2016 Jun; 22(6 Suppl):s159-70.
    View in: PubMed
    Score: 0.015
  5. Egeberg MD, Oh CY, Bainbridge JL. Clinical overview of dalfampridine: an agent with a novel mechanism of action to help with gait disturbances. Clin Ther. 2012 Nov; 34(11):2185-94.
    View in: PubMed
    Score: 0.012
  6. Vande Griend JP, Linnebur SA, Bainbridge JL. Probable levetiracetam-associated depression in the elderly: two case reports. Am J Geriatr Pharmacother. 2009 Oct; 7(5):281-4.
    View in: PubMed
    Score: 0.009
  7. Bainbridge JL, Ruscin JM. Challenges of treatment adherence in older patients with Parkinson's disease. Drugs Aging. 2009; 26(2):145-55.
    View in: PubMed
    Score: 0.009
  8. Bainbridge JL, Page RL, Ruscin JM. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors. Neurol Clin. 2008 Aug; 26(3 Suppl):S85-96, vi.
    View in: PubMed
    Score: 0.009
  9. Page RL, Bainbridge JL. Intractable epistaxis associated with topiramate administration. Ann Pharmacother. 2006 Jul-Aug; 40(7-8):1462-5.
    View in: PubMed
    Score: 0.007
  10. Domen CH, Sillau S, Liu Y, Adkins M, Rajkovic S, Bainbridge J, Sempio C, Klawitter J, Leehey MA. Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and ?9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms. Mov Disord. 2023 07; 38(7):1341-1346.
    View in: PubMed
    Score: 0.006
  11. Kluger BM, Drees C, Wodushek TR, Frey L, Strom L, Brown MG, Bainbridge JL, Fischer SN, Shrestha A, Spitz M. Would people living with epilepsy benefit from palliative care? Epilepsy Behav. 2021 01; 114(Pt A):107618.
    View in: PubMed
    Score: 0.005
  12. Bainbridge JL, Gidal BE, Ryan M. The ketogenic diet. Central Nervous System Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 1999 Jun; 19(6):782-6.
    View in: PubMed
    Score: 0.005
  13. Leehey M, Luo S, Sharma S, Wills AA, Bainbridge JL, Wong PS, Simon DK, Schneider J, Zhang Y, P?rez A, Dhall R, Christine CW, Singer C, Cambi F, Boyd JT. Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores. Neurology. 2017 Oct 24; 89(17):1789-1794.
    View in: PubMed
    Score: 0.004
  14. Gibbons CH, Simon DK, Huang M, Tilley B, Aminoff MJ, Bainbridge JL, Brodsky M, Freeman R, Goudreau J, Hamill RW, Luo ST, Singer C, Videnovic A, Bodis-Wollner I, Wong PS. Autonomic and electrocardiographic findings in Parkinson's disease. Auton Neurosci. 2017 07; 205:93-98.
    View in: PubMed
    Score: 0.004
  15. Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wei P, Wong PS, Yang T. Caffeine, creatine, GRIN2A and Parkinson's disease progression. J Neurol Sci. 2017 Apr 15; 375:355-359.
    View in: PubMed
    Score: 0.004
  16. Garcia-Borreguero D, Silber MH, Winkelman JW, H?gl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Ondo W, Winkelmann J, Allen RP. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016 05; 21:1-11.
    View in: PubMed
    Score: 0.004
  17. Bhakta J, Bainbridge J, Borgelt L. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy. Epilepsy Behav. 2015 Nov; 52(Pt A):212-7.
    View in: PubMed
    Score: 0.004
  18. Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS. Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clin Neuropharmacol. 2015 Sep-Oct; 38(5):163-9.
    View in: PubMed
    Score: 0.004
  19. Augustine EF, P?rez A, Dhall R, Umeh CC, Videnovic A, Cambi F, Wills AM, Elm JJ, Zweig RM, Shulman LM, Nance MA, Bainbridge J, Suchowersky O. Sex Differences in Clinical Features of Early, Treated Parkinson's Disease. PLoS One. 2015; 10(7):e0133002.
    View in: PubMed
    Score: 0.003
  20. Picchietti DL, Hensley JG, Bainbridge JL, Lee KA, Manconi M, McGregor JA, Silver RM, Trenkwalder C, Walters AS. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. Sleep Med Rev. 2015 Aug; 22:64-77.
    View in: PubMed
    Score: 0.003
  21. Page RL, Spurck P, Bainbridge JL, Michalek J, Quaife RA. Seizures associated with regadenoson: a case series. J Nucl Cardiol. 2012 Apr; 19(2):389-91.
    View in: PubMed
    Score: 0.003
  22. Mauldin PD, Guimaraes P, Albin RL, Ray Dorsey E, Bainbridge JL, Siderowf A. Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy. Clin Ther. 2008 Aug; 30(8):1553-7.
    View in: PubMed
    Score: 0.002
  23. Ramsay RE, Uthman B, Pryor FM, Rowan AJ, Bainbridge J, Spitz M, Sirven JI, Frederick TE. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study. Epilepsia. 2008 Jul; 49(7):1180-5.
    View in: PubMed
    Score: 0.002
  24. Page RL, Ruscin JM, Bainbridge JL, Brieke AA. Restless legs syndrome induced by escitalopram: case report and review of the literature. Pharmacotherapy. 2008 Feb; 28(2):271-80.
    View in: PubMed
    Score: 0.002
  25. Turner CJ, Ellis S, Giles J, Maffeo C, Hansen L, Saseen JJ, Ulrich H, Valdez C, Altiere R, Bainbridge J, Page R, Sintek C, Vondracek S, Zadvorny E, Fish D. A strategy to develop advanced pharmacy practice experiences. Am J Pharm Educ. 2007 Jun 15; 71(3):46.
    View in: PubMed
    Score: 0.002
  26. Gottwald MD, Bainbridge JL, Dowling GA, Aminoff MJ, Alldredge BK. New pharmacotherapy for Parkinson's disease. Ann Pharmacother. 1997 Oct; 31(10):1205-17.
    View in: PubMed
    Score: 0.001
  27. Fish DN, Bainbridge JL, Peloquin CA. Variable disposition of ciprofloxacin in critically ill patients undergoing continuous arteriovenous hemodiafiltration. Pharmacotherapy. 1995 Mar-Apr; 15(2):236-45.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)